Description:
Baymedica Inc. is developing a scalable biosynthetic platform to deliver a portfolio of natural cannabinoids including CBC, CBD and CBG as well as novel cannabinoid analogs for life science, pharmaceutical, nutraceutical, cosmetic and animal health applications.